GOSS

Gossamer Bio Inc (GOSS)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 445.67M
P/E Ratio
0.00
Revenue (TTM)
$ 40.24M
Volume
0
52W High
$ 2.23
52W Low
$ 0.66
Dividend Yield
0.00%
Beta
1.96

Technicals

50-Day MA
1.5629
200-Day MA
1.1449
52 Week High
2.23
52 Week Low
0.6617

About GOSS

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

Employees
144
Headquarters
San Diego, CA
CEO
Mr. Faheem Hasnain

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg